Abstract
Purpose
The objective of present work was to develop a mannose-anchored, engineered nanoparticulate system for efficient delivery of amphotericin B to macrophages. Furthermore, the effect of spacer on macrophage targeting was also evaluated.
Methods
PLGA was conjugated to mannose via direct coupling (M-PLGA) and via PEG spacer (M-PEG-PLGA), and engineered PLGA nanoparticles (M-PNPs and M-PEG-PNPs) were prepared from respective conjugates. These prepared engineered PNPs were characterized for size, polydispersity index (PDI), surface charge, and drug entrapment efficiency (% DEE). Transmission electron microscopy (TEM) and atomic force microscopy (AFM) were employed to study the shape and surface morphology of engineered PNPs. Macrophage targeting was evaluated via cellular uptake, ex vivo antileishmanial activity and in vivo biodisposition pattern of engineered PNPs in macrophage-rich organs.
Results
The developed engineered PNPs were found to be of nanometric size (<200 nm) and to have low PDI (<0.162) and good entrapment efficiency (%DEE >53.0%). AFM and TEM revealed that both M-PNPs and M-PEG-PNPs had smooth surface and spherical topography. Engineered PNPs with spacer showed enhanced uptake, potential antileishmanial activity and higher disposition in macrophage-rich organs, suggesting improved macrophage targeting.
Conclusions
The results suggest that engineering of nanoparticles could lead to development of efficient carrier for macrophage targeting.
Similar content being viewed by others
References
Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed Nanotech Bio Med. 2008;4:252–61.
Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy. Cancer Res. 1986;46:6387–92.
Owais M, Gupta CM. Targeted drug delivery to macrophages in parasitic infections. Cur Drug Del. 2005;2(4):311–8.
Chellat F, Merhi Y, Moreau A, Yahia LH. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterial. 2005;26:7260–75.
Nahar M, Dutta T, Murugesan S, Asthana A, Mishra D, Saraf S, et al. Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit Rev Ther Drug Carrier Syst. 2006;23:259–318.
Sharma A, Sharma S, Khuller GK. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. J Antimicrob Chemother. 2004;54(4):761–6.
Kassab R, Parrot-Lopez H, Fessi H, Menaucourt J, Bonaly R, Coulon J. Molecular recognition by kluyveromyces of amphotericin B-loaded, galactose-tagged, poly (lactic acid) microspheres. Bio Org Med Chem. 2002;10:1767–75.
Olivier J, Huertas R, Lee HJ, Calon F, Pardrige WM. Synthesis of Pegylated immunonanoparticles. Pharm Res. 2002;19(8):1137–43.
Sett R, Sarkar K, Das PK. Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease. J Infect Dis. 1993;168(4):994–9.
Ahsan F, Rivas IP, Khan MA, Torres SA. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Contr Rel. 2002;79(1–3):29–40.
Basu MK, Lala S. Macrophage specific drug delivery in experimental leishmaniasis. Curr Mol Med. 2004;4(6):681–9.
Mukhopadhyay A, Basu SK. Intracellular delivery of drugs to macrophages. Adv Biocheml Eng /Biotech. 2003;84:183–209.
Chakraborty P, Bhaduri AN, Das PK. Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis. Biochem Biophy Res Comm. 1990;166:404–11.
Yamashita C, Sone S, Ogura T, Kiwada H. Potential value of cetylmannoside-modified liposomes as carriers of macrophages activators to human blood monocytes. Japan J Cancer Res. 1991;82:569–75.
Muller CD, Schuber F. Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages. Biochem Biophy Acta. 1989;986:97–101.
Barratt GM, Nolibe D, Yapo A, Petit JF, Tenu JP. Use of mannosylated liposomes for in vivo targeting of a macrophages activator and control of artificial pulmonary metastases. Ann Instit Past Imm. 1987;138:437–43.
Garcon N, Gregoriadis G, Taylor M, Summerfield J. Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology. 1988;64:743–9.
Akamatsu K, Nisshikawa M, Takakura Y, Hashida M. Synthesis and biodistribution study of liver-specific prostaglandin E1 polymeric conjugate. Int J Pharm. 1977;155:65. 77.
Mitchell JP, Roberts DR, Langley J, Koentgen F, Lambert JN. A direct method for the formation of peptide and carbohydrate dendrimers. Bio Org Med Chem Lett. 1999;9:2785–8.
Venier-Julienne M, Benoit J. Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Pharm Acta Helv. 1996;71:121–8.
Echevarria I, Barturen C, Renedo MJ, Dios-Vieitez MC. High-performance liquid chromatographic determination of amphotericin B in plasma and tissue; application to pharmacokinetic and tissue distribution studies in rats. J Chromat A. 1998;819:171–6.
Westedt U, Kalinowski M, Ms Wittmar, Merdan T, Unger F, Fuchs J, et al. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J Contr Rel. 2007;119:41–51.
Copland MJ, Baird MA, Rades T, McKenzie JL, Becker B, Reck F, et al. Liposomal delivery of antigen to human dendritic cells. Vaccine. 2003;21:883–90.
Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen loaded modified liposomes. Eur J Pharm Sci. 2008;33:424–33.
Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Contr Rel. 2007;120:18–26.
Dube A, Singh N, Sundar S, Singh N. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persists in in vitro and in vivo experimental models. Parasitol Res. 2005;96:216–23.
Guru PY, Agarwal AK, Singhal UK, Singhal A, Gupta CM. Drug targeting in Leishmania donovani infections using tuftsin bearing liposomes as drug vehicles. FEBS Lett. 1989;245:204–8.
Senthilkumar M, Subramanian G, Ranjitkumar A, Nahar M, Mishra P, Jain NK. PEGylated Poly (Lactide-co-Glycolide) (PLGA) nanoparticulate delivery of Docetaxel: synthesis of diblock copolymers, optimization of preparation variables on formulation characteristics and in vitro release studies. J Biomed Nanotech. 2007;1:52–60.
Dutta T, Jain NK. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochem Biophy Acta. 2007;1770:681–6.
Espuelas MS, Legrand P, Irache JM, Gamazo C, Orecchioni AM, Devissaguet J-Ph, et al. Poly (ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity. Int J Pharm. 1997;158:19–27.
Panyam J, Labhasetwar V. Targeting intracellular targets. Cur Drug Del. 2004;1:235–47.
Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm. 2007;336:367–75.
ACKNOWLEDGEMENTS
Manoj Nahar is thankful to the Indian Council of Medical Research (ICMR, New Delhi, India) for providing financial support. All of the authors express their gratitude to AIMS New Delhi, India; Central Drug Research Institute, Lucknow, India; Bhopal Hospital and Memorial Research Center, Bhopal, India; and Inter University Center, Consortium for Scientific Research, Indore, India for various studies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nahar, M., Jain, N.K. Preparation, Characterization and Evaluation of Targeting Potential of Amphotericin B-Loaded Engineered PLGA Nanoparticles. Pharm Res 26, 2588–2598 (2009). https://doi.org/10.1007/s11095-009-9973-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-009-9973-4